Author
Listed:
- Lorenz Ulrich
(Friedrich-Loeffler-Institut)
- Nico Joel Halwe
(Friedrich-Loeffler-Institut)
- Adriano Taddeo
(Institute of Virology and Immunology
University of Bern)
- Nadine Ebert
(Institute of Virology and Immunology
University of Bern)
- Jacob Schön
(Friedrich-Loeffler-Institut)
- Christelle Devisme
(Institute of Virology and Immunology
University of Bern)
- Bettina Salome Trüeb
(Institute of Virology and Immunology
University of Bern
Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern)
- Bernd Hoffmann
(Friedrich-Loeffler-Institut)
- Manon Wider
(University of Bern)
- Xiaoyu Fan
(Centers for Disease Control and Prevention)
- Meriem Bekliz
(University of Geneva)
- Manel Essaidi-Laziosi
(University of Geneva)
- Marie Luisa Schmidt
(Charité–Universitätsmedizin Berlin, Institute of Virology)
- Daniela Niemeyer
(Charité–Universitätsmedizin Berlin, Institute of Virology
German Centre for Infection Research (DZIF))
- Victor Max Corman
(Charité–Universitätsmedizin Berlin, Institute of Virology
German Centre for Infection Research (DZIF))
- Anna Kraft
(Friedrich-Loeffler-Institut)
- Aurélie Godel
(Institute of Virology and Immunology
University of Bern)
- Laura Laloli
(University of Bern
University of Bern)
- Jenna N. Kelly
(Institute of Virology and Immunology
University of Bern)
- Brenda M. Calderon
(Centers for Disease Control and Prevention)
- Angele Breithaupt
(Friedrich-Loeffler-Institut)
- Claudia Wylezich
(Friedrich-Loeffler-Institut)
- Inês Berenguer Veiga
(Institute of Virology and Immunology
University of Bern)
- Mitra Gultom
(University of Bern
University of Bern)
- Sarah Osman
(Centers for Disease Control and Prevention)
- Bin Zhou
(Centers for Disease Control and Prevention)
- Kenneth Adea
(University of Geneva)
- Benjamin Meyer
(University of Geneva)
- Christiane S. Eberhardt
(University of Geneva
University of Geneva
Center for Vaccinology, Geneva University Hospitals)
- Lisa Thomann
(Institute of Virology and Immunology
University of Bern)
- Monika Gsell
(University of Bern)
- Fabien Labroussaa
(Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern)
- Jörg Jores
(Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern)
- Artur Summerfield
(Institute of Virology and Immunology
University of Bern)
- Christian Drosten
(Charité–Universitätsmedizin Berlin, Institute of Virology
German Centre for Infection Research (DZIF))
- Isabella Anne Eckerle
(University of Geneva
Geneva University Hospitals
Geneva University Hospitals)
- David E. Wentworth
(Centers for Disease Control and Prevention)
- Ronald Dijkman
(University of Bern)
- Donata Hoffmann
(Friedrich-Loeffler-Institut)
- Volker Thiel
(Institute of Virology and Immunology
University of Bern)
- Martin Beer
(Friedrich-Loeffler-Institut)
- Charaf Benarafa
(Institute of Virology and Immunology
University of Bern)
Abstract
Emerging variants of concern (VOCs) are driving the COVID-19 pandemic1,2. Experimental assessments of replication and transmission of major VOCs and progenitors are needed to understand the mechanisms of replication and transmission of VOCs3. Here we show that the spike protein (S) from Alpha (also known as B.1.1.7) and Beta (B.1.351) VOCs had a greater affinity towards the human angiotensin-converting enzyme 2 (ACE2) receptor than that of the progenitor variant S(D614G) in vitro. Progenitor variant virus expressing S(D614G) (wt-S614G) and the Alpha variant showed similar replication kinetics in human nasal airway epithelial cultures, whereas the Beta variant was outcompeted by both. In vivo, competition experiments showed a clear fitness advantage of Alpha over wt-S614G in ferrets and two mouse models—the substitutions in S were major drivers of the fitness advantage. In hamsters, which support high viral replication levels, Alpha and wt-S614G showed similar fitness. By contrast, Beta was outcompeted by Alpha and wt-S614G in hamsters and in mice expressing human ACE2. Our study highlights the importance of using multiple models to characterize fitness of VOCs and demonstrates that Alpha is adapted for replication in the upper respiratory tract and shows enhanced transmission in vivo in restrictive models, whereas Beta does not overcome Alpha or wt-S614G in naive animals.
Suggested Citation
Lorenz Ulrich & Nico Joel Halwe & Adriano Taddeo & Nadine Ebert & Jacob Schön & Christelle Devisme & Bettina Salome Trüeb & Bernd Hoffmann & Manon Wider & Xiaoyu Fan & Meriem Bekliz & Manel Essaidi-La, 2022.
"Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta,"
Nature, Nature, vol. 602(7896), pages 307-313, February.
Handle:
RePEc:nat:nature:v:602:y:2022:i:7896:d:10.1038_s41586-021-04342-0
DOI: 10.1038/s41586-021-04342-0
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:602:y:2022:i:7896:d:10.1038_s41586-021-04342-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.